未登录 Impact of SIRPα genotype combinations in recipients and donors on alloimmune response in liver transplantation 受者与供者SIRPα基因型组合对肝移植中 alloimmune response 的影响 Seidakhmetov, Akhmet; Tanimine, Naoki; Tanaka, Yuka; Arata, Ryosuke; Nakano, Ryosuke; Sakai, Hiroshi; Ohira, Masahiro; Tahara, Hiroyuki; Ide, Kentaro; Kobayashi, Tsuyoshi; Ohdan, Hideki 分享 收藏
Wound, Pressure Ulcer and Burn Guidelines (2023)―5: Guidelines for the Management of Lower Leg Ulcers/Varicose Veins, Third Edition Wound/Pressure Ulcer/Burn Guidelines Drafting Committee (Lower Leg Ulcers/Varicose Veins Group) 《伤口、压力性溃疡和烧伤指南》（2023）―5：下肢溃疡/静脉曲张管理指南，第三版 伤口/压力性溃疡/烧伤指南起草委员会（下肢溃疡/静脉曲张小组） Maekawa, Takeo; Ito, Takaaki; Idezuki, Takeo; Ota, Mayumi; Sakai, Hiroshi; Sarayama, Yasuko; Tanaka, Takamitsu; Niihara, Hiroyuki; Fusumae, Takayuki; Makino, Koji; Yatsushiro, Hiroshi; Kondo, Akiyo; Asano, Yoshihide; Nakanishi, Takeshi; Motegi, Sei-ichiro; Yoshino, Yuichiro; Fujiwara, Hiroshi; Hasegawa, Minoru; Fujimoto, Manabu; Tachibana, Takao 分享 收藏
Long-Term Effects of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention in High-Risk Subgroups Yamamoto, Ko; Yamamoto, Erika; Morimoto, Takeshi; Shiomi, Hiroki; Domei, Takenori; Taniguchi, Ryoji; Sakai, Hiroshi; Toyofuku, Mamoru; Kaji, Shuichiro; Nawada, Ryuzo; Yokomatsu, Takafumi; Suwa, Satoru; Furukawa, Yutaka; Kadota, Kazushige; Ando, Kenji; Kimura, Takeshi 分享 收藏
WJOG (West Japan Oncology Group) Breast Cancer Consensus Meeting 2023 Kimura, Y.; Watanuki, R.; Aoyama, Y.; Sakai, H.; Shimomura, A.; Tsurutani, J.; Tokunaga, S.; Mukohara, T.; Matsumoto, K.; Iwasa, T.; Ozaki, Y.; Nozawa, K.; Terada, M.; Kizawa, R.; Takano, T. 分享 收藏
分享 收藏
Crossmatch-positive, highly sensitized kidney transplant recipients after desensitization with rituximab ± bortezomib. Ide, Kentaro; Tahara, Hiroyuki; Ohira, Masahiro; Nakano, Ryosuke; Sakai, Hiroshi; Ono, Kosuke; Arata, Ryosuke; Hakoda, Keishi; Imaoka, Koki; Fukuhara, Sotaro; Bekki, Tomoaki; Chogahara, Ichiya; Watanabe, Atsuhiro; Tanaka, Yuka; Ohdan, Hideki 分享 收藏
Polypharmacy and Bleeding Outcomes After Percutaneous Coronary Intervention Yamamoto, Ko; Morimoto, Takeshi; Natsuaki, Masahiro; Shiomi, Hiroki; Ozasa, Neiko; Sakamoto, Hiroki; Takeji, Yasuaki; Domei, Takenori; Tada, Takeshi; Taniguchi, Ryoji; Uegaito, Takashi; Yamada, Miho; Takeda, Teruki; Eizawa, Hiroshi; Suwa, Satoru; Shirotani, Manabu; Tamura, Toshihiro; Inoko, Moriaki; Sakai, Hiroshi; Ishii, Katsuhisa; Toyofuku, Mamoru; Miki, Shinji; Onodera, Tomoya; Furukawa, Yutaka; Inada, Tsukasa; Ando, Kenji; Kadota, Kazushige; Nakagawa, Yoshihisa; Kimura, Takeshi 分享 收藏
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION 特波替尼在MET外显子14跳跃的亚洲晚期NSCLC患者中的疗效和安全性 Kato, Terufumi; Yang, James Chih-Hsin; Ahn, Myung-Ju; Sakai, Hiroshi; Morise, Masahiro; Chen, Yuh-Min; Han, Ji-Youn; Yang, Jin-Ji; Zhao, Jun; Hsia, Te-Chun; Berghoff, Karin; Bruns, Rolf; Vioix, Helene; Lang, Simone; Johne, Andreas; Le, Xiuning; Paik, Paul K. 分享 收藏
Association between skin toxicity and ef fi cacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM Watanabe, S.; Yoshioka, H.; Sakai, H.; Hotta, K.; Takenoyama, M.; Yamada, K.; Sugawara, S.; Takiguchi, Y.; Hosomi, Y.; Tomii, K.; Niho, S.; Nishio, M.; Kato, T.; Takahashi, T.; Ebi, H.; Aono, M.; Yamamoto, N.; Ohe, Y.; Nakagawa, K. 分享 收藏
Clopidogrel Use in CYP2C19 Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention Sawayama, Yuichi; Tomita, Yukinori; Kohyama, Soji; Higo, Yosuke; Kodama, Kenji; Asada, Kohei; Yagi, Noriaki; Fukuyama, Megumi; Hayashi, Atsushi; Shioyama, Wataru; Sakai, Hiroshi; Ozawa, Tomoya; Isono, Tetsuichiro; Hira, Daiki; Yamamoto, Takashi; Morita, Shin-ya; Nakagawa, Yoshihisa 分享 收藏
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in metastatic non-small cell lung cancer: CheckMate 9LA 2-year patient-reported outcomes 一线nivolumab联合ipilimumab两周期化疗与单纯化疗 (四个周期) 治疗转移性非小细胞肺癌: CheckMate 9LA 2年患者报告的结果 Reck, Martin; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Cheng, Ying; Sakai, Hiroshi; Paz-Ares, Luis; Lu, Shun; John, Thomas; Sun, Xiaowu; Moisei, Aniela; Taylor, Fiona; Lawrance, Rachael; Zhang, Xiaoqing; Sylvester, Judi; Yuan, Yong; Blum, Steven I.; Penrod, John R.; Carbone, David P. 分享 收藏
Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review MET酪氨酸激酶抑制剂在MET外显子14跳跃非小细胞肺癌患者中的安全性: 临床综述 Cortot, Alexis; Le, Xiuning; Smit, Egbert; Viteri, Santiago; Kato, Terufumi; Sakai, Hiroshi; Park, Keunchil; Camidge, D. Ross; Berghoff, Karin; Vlassak, Soetkin; Paik, Paul K. 分享 收藏
Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan-From the CREDO-Kyoto Registry Cohort-2 and Cohort-3 Natsuaki, Masahiro; Morimoto, Takeshi; Shiomi, Hiroki; Yamamoto, Ko; Yamaji, Kyohei; Watanabe, Hirotoshi; Uegaito, Takashi; Matsuda, Mitsuo; Tamura, Toshihiro; Taniguchi, Ryoji; Inoko, Moriaki; Mabuchi, Hiroshi; Takeda, Teruki; Domei, Takenori; Shirotani, Manabu; Ehara, Natsuhiko; Eizawa, Hiroshi; Ishii, Katsuhisa; Tanaka, Masaru; Inada, Tsukasa; Onodera, Tomoya; Nawada, Ryuzo; Shinoda, Eiji; Yamada, Miho; Yamamoto, Takashi; Sakai, Hiroshi; Toyofuku, Mamoru; Tamura, Takashi; Takahashi, Mamoru; Tada, Tomohisa; Sakamoto, Hiroki; Tada, Takeshi; Kaneda, Kazuhisa; Miki, Shinji; Aoyama, Takeshi; Suwa, Satoru; Sato, Yukihito; Ando, Kenji; Furukawa, Yutaka; Nakagawa, Yoshihisa; Kadota, Kazushige; Kimura, Takeshi 分享 收藏
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice Tepotinib在MET外显子14跳过NSCLC患者中的疗效和安全性: 视觉研究患者亚组的结果与临床实践的相关性 Le, Xiuning; Sakai, Hiroshi; Felip, Enriqueta; Veillon, Remi; Garassino, Marina Chiara; Raskin, Jo; Cortot, Alexis B.; Viteri, Santiago; Mazieres, Julien; Smit, Egbert F.; Thomas, Michael; Iams, Wade T.; Cho, Byoung Chul; Kim, Hye Ryun; Yang, James Chih-Hsin; Chen, Yuh-Min; Patel, Jyoti D.; Bestvina, Christine M.; Park, Keunchil; Griesinger, Frank; Johnson, Melissa; Gottfried, Maya; Britschgi, Christian; Heymach, John; Sikoglu, Elif; Berghoff, Karin; Schumacher, Karl-Maria; Bruns, Rolf; Otto, Gordon; Paik, Paul K. 分享 收藏
First-line nivolumab plus ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients nivolumab联合ipilimumab一线治疗晚期NSCLC: 亚洲患者CheckMate 227亚群分析 O'Byrne, K. J.; Lee, K. H.; Kim, S-W; Park, K.; Nishio, M.; Sakai, H.; Ohe, Y.; Fukuhara, T.; Kang, J-H; Daga, H.; Yu, C-J; Hotta, K.; Tanaka, H.; Takeda, M.; Yokoyama, T.; Nathan, F. E.; Lee, J-S 分享 收藏
First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update (vol 6, 100273, 2021) Reck, M.; Ciuleanu, T. -E.; Cobo, M.; Schenker, M.; Zurawski, B.; Menezes, J.; Richardet, E.; Bennouna, J.; Felip, E.; Juan-Vidal, O.; Alexandru, A.; Sakai, H.; Lingua, A.; Reyes, F.; Souquet, P. -J.; De Marchiy, P.; Martin, C.; Perol, M.; Scherpereel, A.; Lu, S.; Paz-Ares, L.; Carbone, D. P.; Memaj, A.; Marimuthu, S.; Zhang, X.; Tran, P.; John, T. 分享 收藏
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update 一线nivolumab联合ipilimumab两周期化疗与单纯化疗 (四个周期) 治疗晚期非小细胞肺癌: CheckMate 9LA 2年更新 Reck, M.; Ciuleanu, T. -E.; Cobo, M.; Schenker, M.; Zurawski, B.; Menezes, J.; Richardet, E.; Bennouna, J.; Felip, E.; Juan-Vidal, O.; Alexandru, A.; Sakai, H.; Lingua, A.; Reyes, F.; Souquet, P. -J.; De Marchiy, P.; Martin, C.; Perol, M.; Scherpereel, A.; Lu, S.; Paz-Ares, L.; Carbone, D. P.; Memaj, A.; Marimuthu, S.; Zhang, X.; Tran, P.; John, T. 分享 收藏
IMpower010: Sites of relapse and subsequent therapy from a phase III study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC Felip, E.; Vallieres, E.; Zhou, C.; Wakelee, H.; Bondarenko, I.; Sakai, H.; Saito, H.; Ursol, G.; Kawaguchi, K.; Liu, Y.; Levchenko, E.; Kislov, N.; Reck, M.; Liersch, R.; McNally, V. A.; Zhu, Q.; Ding, B.; Bennett, E.; Gitlitz, B.; Altorki, N. K. 分享 收藏
Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC Garassino, M. C. C.; Felip, E.; Sakai, H.; Le, X.; Veillon, R.; Smit, E. F. F.; Mazieres, J.; Cortot, A. B.; Raskin, J.; Thomas, M.; Viteri, S.; Iams, W. T.; Kim, H. R.; Yang, J.; Berghoff, K.; Bruns, R.; Otto, G.; Paik, P. K. 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
dermatology.png)
.png){kind=icon}
分享.png){kind=icon}
收藏